4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide

C132H187N11O31 — CID 161311506

IUPAC4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide
SMILESCC(=O)C(CC(=O)C(CCC(=O)O)CC(=O)C(CCC(=O)O)CC(=O)C(CC(=O)C(CCCCN)CC(=O)C(CC(=O)C(CC(N)=O)CC(=O)C(CC(N)=O)CC(=O)C(C)CCCN=C(N)N)Cc1ccccc1)C(C)O)Cc1ccc(O)cc1.CCC(=O)C(CCCCN)CC(=O)CCC(=O)C(CCCN=C(N)N)CC(=O)C(CO)CC(=O)CCC(=O)CCC(=O)C(CC(=O)C(CC(=O)C(CC(=O)C(NC(=O)CCCC(C)C)C(C)O)Cc1ccccc1)Cc1ccccc1)Cc1ccc(O)cc1
InChIInChI=1S/C70H99N5O14.C62H88N6O17/c1-5-61(82)51(21-12-13-34-71)39-60(81)31-33-62(83)52(22-15-35-74-70(72)73)41-66(87)56(45-76)40-59(80)29-28-58(79)30-32-63(84)53(38-50-24-26-57(78)27-25-50)42-64(85)54(36-48-17-8-6-9-18-48)43-65(86)55(37-49-19-10-7-11-20-49)44-67(88)69(47(4)77)75-68(89)23-14-16-46(2)3;1-36(10-9-23-68-62(66)67)50(72)30-46(33-58(64)80)55(77)32-47(34-59(65)81)54(76)31-45(25-39-11-5-4-6-12-39)53(75)26-41(13-7-8-22-63)56(78)35-49(38(3)70)57(79)28-43(17-21-61(84)85)51(73)27-42(16-20-60(82)83)52(74)29-44(37(2)69)24-40-14-18-48(71)19-15-40/h6-11,17-20,24-27,46-47,51-56,69,76-78H,5,12-16,21-23,28-45,71H2,1-4H3,(H,75,89)(H4,72,73,74);4-6,11-12,14-15,18-19,36,38,41-47,49,70-71H,7-10,13,16-17,20-35,63H2,1-3H3,(H2,64,80)(H2,65,81)(H,82,83)(H,84,85)(H4,66,67,68)
InChIKeyVIYIRMSXFMIACC-UHFFFAOYSA-N
MW2423.99 g/mol
LogP11.82
Rot. Bonds98

About 4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide

4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide (PubChem CID 161311506) has the molecular formula C132H187N11O31 and a molecular weight of 2423.99 g/mol. Its IUPAC name is 4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide.

Molecular Properties

Compound Name4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide
PubChem CID161311506
Molecular FormulaC132H187N11O31
Molecular Weight2423.99 g/mol
Exact Mass2422.34
IUPAC Name4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide
SMILESCC(=O)C(CC(=O)C(CCC(=O)O)CC(=O)C(CCC(=O)O)CC(=O)C(CC(=O)C(CCCCN)CC(=O)C(CC(=O)C(CC(N)=O)CC(=O)C(CC(N)=O)CC(=O)C(C)CCCN=C(N)N)Cc1ccccc1)C(C)O)Cc1ccc(O)cc1.CCC(=O)C(CCCCN)CC(=O)CCC(=O)C(CCCN=C(N)N)CC(=O)C(CO)CC(=O)CCC(=O)CCC(=O)C(CC(=O)C(CC(=O)C(CC(=O)C(NC(=O)CCCC(C)C)C(C)O)Cc1ccccc1)Cc1ccccc1)Cc1ccc(O)cc1
InChIInChI=1S/C70H99N5O14.C62H88N6O17/c1-5-61(82)51(21-12-13-34-71)39-60(81)31-33-62(83)52(22-15-35-74-70(72)73)41-66(87)56(45-76)40-59(80)29-28-58(79)30-32-63(84)53(38-50-24-26-57(78)27-25-50)42-64(85)54(36-48-17-8-6-9-18-48)43-65(86)55(37-49-19-10-7-11-20-49)44-67(88)69(47(4)77)75-68(89)23-14-16-46(2)3;1-36(10-9-23-68-62(66)67)50(72)30-46(33-58(64)80)55(77)32-47(34-59(65)81)54(76)31-45(25-39-11-5-4-6-12-39)53(75)26-41(13-7-8-22-63)56(78)35-49(38(3)70)57(79)28-43(17-21-61(84)85)51(73)27-42(16-20-60(82)83)52(74)29-44(37(2)69)24-40-14-18-48(71)19-15-40/h6-11,17-20,24-27,46-47,51-56,69,76-78H,5,12-16,21-23,28-45,71H2,1-4H3,(H,75,89)(H4,72,73,74);4-6,11-12,14-15,18-19,36,38,41-47,49,70-71H,7-10,13,16-17,20-35,63H2,1-3H3,(H2,64,80)(H2,65,81)(H,82,83)(H,84,85)(H4,66,67,68)
InChIKeyVIYIRMSXFMIACC-UHFFFAOYSA-N
XLogP11.82
TPSA796.20 Ų
H-Bond Donors16
H-Bond Acceptors33
Rotatable Bonds98
Heavy Atoms174
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002423.99
LogP ≤ 511.82
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide?
The IUPAC name of 4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide (CID 161311506) is 4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide.
What is the SMILES notation for 4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide?
The canonical SMILES for 4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide is CC(=O)C(CC(=O)C(CCC(=O)O)CC(=O)C(CCC(=O)O)CC(=O)C(CC(=O)C(CCCCN)CC(=O)C(CC(=O)C(CC(N)=O)CC(=O)C(CC(N)=O)CC(=O)C(C)CCCN=C(N)N)Cc1ccccc1)C(C)O)Cc1ccc(O)cc1.CCC(=O)C(CCCCN)CC(=O)CCC(=O)C(CCCN=C(N)N)CC(=O)C(CO)CC(=O)CCC(=O)CCC(=O)C(CC(=O)C(CC(=O)C(CC(=O)C(NC(=O)CCCC(C)C)C(C)O)Cc1ccccc1)Cc1ccccc1)Cc1ccc(O)cc1.
What is the InChIKey of 4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide?
The InChIKey is VIYIRMSXFMIACC-UHFFFAOYSA-N. The full InChI is InChI=1S/C70H99N5O14.C62H88N6O17/c1-5-61(82)51(21-12-13-34-71)39-60(81)31-33-62(83)52(22-15-35-74-70(72)73)41-66(87)56(45-76)40-59(80)29-28-58(79)30-32-63(84)53(38-50-24-26-57(78)27-25-50)42-64(85)54(36-48-17-8-6-9-18-48)43-65(86)55(37-49-19-10-7-11-20-49)44-67(88)69(47(4)77)75-68(89)23-14-16-46(2)3;1-36(10-9-23-68-62(66)67)50(72)30-46(33-58(64)80)55(77)32-47(34-59(65)81)54(76)31-45(25-39-11-5-4-6-12-39)53(75)26-41(13-7-8-22-63)56(78)35-49(38(3)70)57(79)28-43(17-21-61(84)85)51(73)27-42(16-20-60(82)83)52(74)29-44(37(2)69)24-40-14-18-48(71)19-15-40/h6-11,17-20,24-27,46-47,51-56,69,76-78H,5,12-16,21-23,28-45,71H2,1-4H3,(H,75,89)(H4,72,73,74);4-6,11-12,14-15,18-19,36,38,41-47,49,70-71H,7-10,13,16-17,20-35,63H2,1-3H3,(H2,64,80)(H2,65,81)(H,82,83)(H,84,85)(H4,66,67,68).
What are the key properties of 4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide?
4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide has a molecular weight of 2423.99 g/mol, XLogP of 11.82, 98 rotatable bonds, 16 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[6-(4-aminobutyl)-12,15-bis(2-amino-2-oxoethyl)-9-benzyl-21-(diaminomethylideneamino)-3-(1-hydroxyethyl)-18-methyl-2,5,8,11,14,17-hexaoxohenicosyl]-7-[3-[(4-hydroxyphenyl)methyl]-4-oxopentanoyl]-5-oxodecanedioic acid;N-[34-amino-6,9-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-2-hydroxy-21-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-4,7,10,13,16,19,22,25,28-nonaoxo-30-propanoyltetratriacontan-3-yl]-5-methylhexanamide is sourced from PubChem (CID 161311506), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).